121 related articles for article (PubMed ID: 15818612)
1. Peroxisome proliferator-activated receptor gamma agonist troglitazone induces colon tumors in normal C57BL/6J mice and enhances colonic carcinogenesis in Apc1638 N/+ Mlh1+/- double mutant mice.
Yang K; Fan KH; Lamprecht SA; Edelmann W; Kopelovich L; Kucherlapati R; Lipkin M
Int J Cancer; 2005 Sep; 116(4):495-9. PubMed ID: 15818612
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice.
Osawa E; Nakajima A; Wada K; Ishimine S; Fujisawa N; Kawamori T; Matsuhashi N; Kadowaki T; Ochiai M; Sekihara H; Nakagama H
Gastroenterology; 2003 Feb; 124(2):361-7. PubMed ID: 12557142
[TBL] [Abstract][Full Text] [Related]
3. The PPAR(gamma) K422Q mutation does not contribute to troglitazone inefficiency in colon cancer treatment.
Bouancheau D; Buecher B; Jarry A; Simon B; Masson D; Cassagnau E; Hamelin R; Laboisse CL; Bézieau S; Denis MG
Cancer Lett; 2005 Jun; 224(1):111-6. PubMed ID: 15911106
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo therapeutic efficacy of the PPAR-γ agonist troglitazone in combination with cisplatin against malignant pleural mesothelioma cell growth.
Hamaguchi N; Hamada H; Miyoshi S; Irifune K; Ito R; Miyazaki T; Higaki J
Cancer Sci; 2010 Sep; 101(9):1955-64. PubMed ID: 20608936
[TBL] [Abstract][Full Text] [Related]
5. Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth.
Li M; Lee TW; Mok TS; Warner TD; Yim AP; Chen GG
J Cell Biochem; 2005 Nov; 96(4):760-74. PubMed ID: 16149072
[TBL] [Abstract][Full Text] [Related]
6. Tumor-associated Apc mutations in Mlh1-/- Apc1638N mice reveal a mutational signature of Mlh1 deficiency.
Kuraguchi M; Edelmann W; Yang K; Lipkin M; Kucherlapati R; Brown AM
Oncogene; 2000 Nov; 19(50):5755-63. PubMed ID: 11126362
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.
Memon RA; Tecott LH; Nonogaki K; Beigneux A; Moser AH; Grunfeld C; Feingold KR
Endocrinology; 2000 Nov; 141(11):4021-31. PubMed ID: 11089532
[TBL] [Abstract][Full Text] [Related]
8. Sulindac effects on inflammation and tumorigenesis in the intestine of mice with Apc and Mlh1 mutations.
Itano O; Yang K; Fan K; Kurihara N; Shinozaki H; Abe S; Jin B; Gravaghi C; Edelmann W; Augenlicht L; Kopelovich L; Kucherlapati R; Lamprecht S; Lipkin M
Carcinogenesis; 2009 Nov; 30(11):1923-6. PubMed ID: 19755659
[TBL] [Abstract][Full Text] [Related]
9. The effect of PPARgamma ligands on UV- or chemically-induced carcinogenesis in mouse skin.
He G; Muga S; Thuillier P; Lubet RA; Fischer SM
Mol Carcinog; 2005 Aug; 43(4):198-206. PubMed ID: 15864802
[TBL] [Abstract][Full Text] [Related]
10. Tumorigenesis in Mlh1 and Mlh1/Apc1638N mutant mice.
Edelmann W; Yang K; Kuraguchi M; Heyer J; Lia M; Kneitz B; Fan K; Brown AM; Lipkin M; Kucherlapati R
Cancer Res; 1999 Mar; 59(6):1301-7. PubMed ID: 10096563
[TBL] [Abstract][Full Text] [Related]
11. Chemopreventive effect of peroxisome proliferator-activated receptor gamma on gastric carcinogenesis in mice.
Lu J; Imamura K; Nomura S; Mafune K; Nakajima A; Kadowaki T; Kubota N; Terauchi Y; Ishii G; Ochiai A; Esumi H; Kaminishi M
Cancer Res; 2005 Jun; 65(11):4769-74. PubMed ID: 15930296
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor γ ligand troglitazone and TRAIL synergistically induce apoptosis.
Koyama M; Sowa Y; Horinaka M; Goda AE; Fujiwara J; Sakai T
Oncol Rep; 2014 Feb; 31(2):947-54. PubMed ID: 24276615
[TBL] [Abstract][Full Text] [Related]
13. Ligands for peroxisome proliferator-activated receptors alpha and gamma inhibit chemically induced colitis and formation of aberrant crypt foci in rats.
Tanaka T; Kohno H; Yoshitani S; Takashima S; Okumura A; Murakami A; Hosokawa M
Cancer Res; 2001 Mar; 61(6):2424-8. PubMed ID: 11289109
[TBL] [Abstract][Full Text] [Related]
14. Promotion of colon tumors in C57BL/6J-APC(min)/+ mice by thiazolidinedione PPARgamma agonists and a structurally unrelated PPARgamma agonist.
Pino MV; Kelley MF; Jayyosi Z
Toxicol Pathol; 2004; 32(1):58-63. PubMed ID: 14713549
[TBL] [Abstract][Full Text] [Related]
15. Troglitazone attenuates epidermal growth factor receptor signaling independently of peroxisome proliferator-activated receptor in PC-3 cells.
Zhu H; Pan X; Qi H; Wang X; Hou S; Han B; Liu Z; Xu L
Oncol Rep; 2011 Jan; 25(1):81-90. PubMed ID: 21109961
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-gamma- and ERK-dependent in human non-small lung cancer cells.
Li M; Lee TW; Yim AP; Mok TS; Chen GG
J Cell Physiol; 2006 Nov; 209(2):428-38. PubMed ID: 16883598
[TBL] [Abstract][Full Text] [Related]
17. Effect of troglitazone on CYP1A1 induction.
Kim HG; Han EH; Jeong HG
Toxicology; 2008 Apr; 246(2-3):166-71. PubMed ID: 18308446
[TBL] [Abstract][Full Text] [Related]
18. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S
Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600
[TBL] [Abstract][Full Text] [Related]
19. Piroxicam increases colon tumorigenesis and promotes apoptosis in Mlh1 +/- /Apc1638(N/+) mice.
Palmerini E; Fan K; Yang K; Risio M; Edelmann W; Lipkin M; Biasco G
Anticancer Res; 2007; 27(6B):3807-12. PubMed ID: 18225536
[TBL] [Abstract][Full Text] [Related]
20. Troglitazone inhibits cell growth and induces apoptosis of B-cell acute lymphoblastic leukemia cells with t(14;18).
Takenokuchi M; Saigo K; Nakamachi Y; Kawano S; Hashimoto M; Fujioka T; Koizumi T; Tatsumi E; Kumagai S
Acta Haematol; 2006; 116(1):30-40. PubMed ID: 16809887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]